Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.

Keyphrases

• Cross-reactivity 100%
• Plaque 100%
• Low Molecular Weight Heparin 100%
• Eczematous 100%
• Danaparoid 100%
• Dalteparin 50%
• Enoxaparin 50%
• Skin Reactions 50%
• Number of Patients 25%
• Pregnant Women 25%
• During Pregnancy 25%
• Heparin 25%
• Clinical High Risk 25%
• Pregnancy Complications 25%
• Selective Intrauterine Growth Restriction (sIUGR) 25%
• Pregnancy Loss 25%
• Early-onset Preeclampsia 25%
• Patchy 25%
• Congenital Thrombophilia 25%
• Heparinoid 25%
• Acquired Thrombophilia 25%

Medicine and Dentistry

• Cross Reaction 100%
• Low Molecular Weight Heparin 100%
• Danaparoid 100%
• Skin Manifestation 50%
• Dalteparin Sodium 50%
• Pre-Eclampsia 25%
• Heparin 25%
• Side Effect 25%
• Pregnancy Complication 25%
• Intrauterine Growth Retardation 25%
• Thrombophilia 25%
• Heparinoid 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Low Molecular Weight Heparin 100%
• Danaparoid 100%
• Dalteparin 50%
• Enoxaparin 50%
• Skin Manifestation 50%
• Side Effect 25%
• Heparin 25%
• Pregnancy Complication 25%
• Preeclampsia 25%
• Intrauterine Growth Retardation 25%
• Thrombophilia 25%
• Heparinoid 25%